A new kind of blood test promises to find cancer early – sometimes even before symptoms appear. The pitch is compelling: a single sample of blood could scan the body for dozens of different can ...
Their makers claim they can detect dozens of cancer types — but some scientists say they could be missing many cancers or ...
Metastatic prostate cancer is currently associated with high morbidity and mortality rates. In addition, patients respond very differently to standard treatments such as hormone therapy or radiation ...
Proteomics International has launched PromarkerEso at the ISDE World Congress in Brisbane (18–20 September). PromarkerEso is a world-first protein biomarker-based blood diagnostic that can rule out ...
Expanded cohort reiterates strong adherence rate of over 90% for Shield blood-based colorectal cancer screening test Survey findings show eligible individuals prefer a blood test for colorectal cancer ...
UC San Diego Health is the first health system in the country to offer a new blood test for testicular cancer, officials announced Monday. The test, a decade in the making, is being touted by UCSD ...
Kentucky has one of the highest rates of colorectal cancer in the US, but early detection leads to a 91% five-year survival rate. Colorectal cancer is projected to become the leading cancer killer for ...
Dec. 2 (UPI) --As new blood tests capable of detecting dozens of cancers in their early stages are hitting the market, disease prevention advocates say political and economic momentum is building for ...
UC San Diego Health is the first health system in the country to offer a new blood test for testicular cancer, officials announced Monday. The test, a decade in the making, is being touted by UCSD ...
Roche has claimed the exclusive international rights to Freenome’s multiomic cancer screening approaches, toward the goal of developing blood testing kits for markets outside the U.S. The licensing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results